A method or apparatus for three-dimensionally printing. The method may comprise causing a phase change in a region of the first material by applying focused energy to the region using a focused energy source, and displacing the first material with a second material. The apparatus may comprise a container configured to hold a first material, a focused energy source configured to cause a phase change in a region of the first material by applying focused energy to the region, and an injector configured to displace the first material with a second material. The first material may comprise a yield stress material, which is a material exhibiting Herschel-Bulkley behavior. The yield stress material may comprise a soft granular gel. The second material may comprise one or more cells.

A shaped article comprising a polymer-based resin derived from cellulose, wherein the polymer-based resin has an HDT of at least 95° C., a bio-derived content of at least 20 wt %, a notched izod impact strength of greater than 80 J/m and at least one of the following properties chosen from: flexural modulus of greater than 1900 MPa; a spiral flow length or at least 3.0 cm; a flex creep deflection of less than 12 mm; a transmission of at least 70%; a ΔE value of less than 25; or an L* color of at least 85.

The present invention relates to a solid form, particularly to a 3D-printed immediate release solid dosage form (e.g. based on a pharmaceutical, nutraceutical, or food supplement composition). To overcome some of the solubility and disintegration problems inherited by 3D-printed solid dosage forms, the solid form comprises one or more channels, generally in the form of tubular passages or grooves, through the body of the solid form or the surface thereof.

Non-invasive Ocular Drug Delivery Insert Technology. The invention concerns an ocular insert which is a new biocompatible polymer-based controlled drug delivery system (CDDS) applicable to a variety of drugs and other compounds for the treatment of different ocular pathologies. This ocular insert allows releasing of at least one drug under suitable concentration levels during suitable periods of time. The device may be inserted in the lower or upper fornix conjunctiva, in a non-invasive way, meaning that the patient will be able to place the device himself, without intervention of medical specialized staff. The insert of the invention will release the drug in such a controlled rate that will allow the drug release up to 300 days by either a “Fickian” or a linear profile according to the intend purpose or pathology. The insert can be prepared with different shapes (spherical or spherical dome) and/or architectures (monolithic/layered either with or without a drug core) allowing the incorporation of at least one drug which can be released at different rates. The size, shape and design of the insert is adjusted in order to tune the drug(s) delivery profile(s) and to inhibit the risk of displacement or expulsion.

A novel cutting-edge structure and method and apparatus for manufacturing the cutting-edge structure is provided. The cutting-edge structure is comprised of naturally derived or renewable material at greater than 50% by volume fraction. In one embodiment, the naturally derived material is a cellulose nanostructure such as a cellulose nanocrystal. The cellulose nanocrystal is processed using a base or mold structure to provide a cutting edge of any shape such as linear or circular edge structures. The process includes dual cure steps to produce an optimal cutting-edge structure without shrinkage. The formed cutting-edge structure can be utilized as a razor blade as it is formed with very sharp tip and edge suitable for cutting hair. The base structure can form one or more cutting-edge structures simultaneously.

A bedding product having a cooling layer and a method therefor. The bedding product has a gel layer having an outside surface, a bonding surface opposite the outside surface, and a perimeter. A memory foam layer surrounds the perimeter and is disposed on the bonding surface. A textile layer having a first rectangular portion and a second rectangular portion affixed on a perimeter thereof to the first rectangular portion retains the gel layer and memory foam layer therebetween. The textile layer has a cooling surface, an opposing surface opposite the cooling surface, and at least one vent disposed adjacent to an edge portion of the first or second rectangular portion. The gel layer contains a plurality of hexagonal prism-shaped peaks and valleys on the outside surface thereof, and the gel layer and memory foam layer have a plurality of air conduits for air flow communication with the vent.

A system and method for forming plastic sheet into a three-dimensional shape. The plastic sheet may include one or more sheet-mounted components, such as electronics, that must be shielded from excessive heat, pressure, and/or crushing when the formation of the sheet occurs. A recess will be formed to protect against directly contacting sheet-mounted component. The recess may be aligned along the heating plate and/or the form core and/or along a protective blanket which may be set over (and under) sheet prior to heating/forming. The sheet is registered (with or without a blanket) onto a base plate, and preferably over a form core. The sheet is then raised to contact with a heating plate, and then placed downward over the (optionally heated) form core. Recess(es) align in locations corresponding to mounted component to protect same.

A three-dimensional object comprises stacked substrate layers infiltrated by a hardened material. Each substrate layer is a sheet-like structure that comprises fibers held together by a sodium silicate binder. The substrate layer material may be non-woven or woven. The substrate layer may be a non-woven fiber veil bound by a sodium silicate binder. The fibers may optionally include carbon fibers, ceramic fibers, polymer fibers, glass fibers, metal fibers, or a combination thereof.

The present disclosure provides a process. In an embodiment, the process includes elongating a multilayer film to a impart a haze value greater than 30% to the multilayer film. The multilayer film has at least two layers: (A) a core layer composed of an ethylene/α-olefin multi-block copolymer and (B) a first skin layer in contact with the core layer, the skin layer composed of an ethylene-based polymer. The process includes releasing the elongating force from the elongated multilayer film to form a hazed multilayer film having a haze value greater than 30%. The process includes stretching the hazed multilayer film to form a stretched multilayer film having a clarity value greater than 80%. The process includes relaxing the stretch force from the stretched multilayer film to form a relaxed multilayer film having a haze value greater than 30%.

A photocurable transparent ink composition for three-dimensional molding includes the following components in parts by weight: 60-125 parts of a photocuring agent, 0.01-5 parts of a yellowing adjusting agent, 0.5-5 parts of a photoinitiator, and 0.5-5 parts of an auxiliary agent, where the yellowing adjusting agent can absorb light in a wavelength range of 560 nm to 650 nm, so that the ink composition appears transparent. The photocurable transparent ink composition for three-dimensional molding can prevent yellowing of a printed article and make the printed article show a whiter, more transparent, and brighter appearance.